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ABSTRACT
 Diabetic patients suffer from inflammation and immune deficiency due to the
 decrease macrophage activity that lead to vulnerable to infection. Phaleria macrocarpa
 (Scheff.) Boerl leaf extract has been proven increase macrophage activity and to have
 antiinflammatory effect. This study was conducted to investigate effect of ethanolic
 extract of P. macrocarpa (Sheff.) Boerl leaf (EEPML) on macrophage phagocytic activity
 in diabetic rat model. In addition, the M1 and M2 macrophage ratio was also evaluated.
 This was quasi experimental study with post test only control group design. Forty five
 male Sprague Dawley rats aged eight weeks were grouped into non diabetic control
 group, diabetic control group and diabetic treatment group which given with 7; 14; 28
 mg/200 g body weight (BW) of EEPML respectively, orally once a day for 3, 14 or 25
 days. Diabetic rats were induced by intraperitoneal injection of streptozotocin (STZ) at a
 dose of 65 mg/kg BW and nicotimamide at 100 mg/kg BW. Peritoneal fluid was isolated
 on day 3, 14 and 25 and cultured for the assay of macrophage phagocytic activity
 with latex beads. M1 and M2 macrophage percentages were analyzed by flowcytometry
 with anti CD40 and CD206 antibody. The results showed that the mean of active
 macrophages and macrophages phagocytic index of EEPML treatment groups on day 3,
 14 and 25 were significantly higher than those in the diabetic control group (p<0.05).
 Moreover, the mean of M1 macrophage percentage of EEPML treatment groups were
 significantly higher on day 14 but significantly lower on day 25 than that in the diabetic
 control group (p<0.05). In addition, the mean of M2 macrophage percentage was not
 significantly difference among the groups (p>0.05). In conclusion, the ethanolic extract
 of P. macrocarpa (Sheff.) Boerl leaf administration can increase macrophage phagocytic
 activity in diabetic rats. In addition, it also can increase M1 macrophage percentage on
 .day 14
ABSTRAK
Penderita diabetes mengalami inflamasi dan penurunan sistem imun akibat menurunnya 
aktivitas sehingga rentan terhadap infeksi. Ekstrak daun mahkota dewa (Phleria 
macrocarpa (Scheff.) Boerl) telah dibuktikan dapat meningkatkan aktivitas makrofag 
dan mempunyai efek antiinflamasi. Penelitian ini bertujuan untuk mengkaji efek ekstrak 
etanol daun mahkota dewa (EEMD) terhadap aktivitas fagositosis makrofag pada tikus 
model diabetes. Selain itu rasio makrofag M1 dan M2 juga dihitung. Penelitian ini adalah 
141
Ira Cinta Lestari et al., The effects of ethanolic extract of Phaleria macrocarpa (Scheff.) 
Boerl leaf on macrophage phagocytic activity in diabetic rat model
penelitian eksperimental semu dengan rancangan uji akhir dan kelompok control. Empat 
puluh lima tikus jantan Sprague Daley berumus delapan minggu dikelompokkan menjadi 
kelompok kontrol non diabetes, kelompok kontrol diabetes dan kelompok perlakuan EEMD 
dosis 7, 14 dan 28 mg/kg berat badan secara oral sekali sehari selama 3, 14 atau 25 hari. 
Tikus dibuat diabetes dengan diinduksi streptozotosin dosis 65 mg/kg berat badan dan 
nikotinamid 100 mg/kg berat badan secara intraperitonial. Cairan peritonial tikus diisolasi 
pada hari ke 3, 14 dan 25 dan dikultur untuk pengujian aktivitas fagositosis makrofag 
terhadap partikel lateks. Persentase makrofag M1 dan M2 dianalisis dengan flositometri 
menggunakan anti CD40 and antibody CD206. Hasil penelitian menunjukkan rerata 
makrofag aktif dan indeks fagositosis makrofag kelompok perlakuan EEMD pada hari ke 3, 
14 dan 25 lebih tinggi secara bermakna dibandingkan dengan kontrol diabetes (p<0.05). 
Selanjutnya, rerata persentase makrofag M1 kelomppok perlakuan EEDM pada hari ke 
14 lebih tinggi secara bermakna dibandingkan dengan kontrol diabetes (p<0.05), akan 
tetapi lebih rendah secara bermakna pada hari ke 25 (p<0.05). Sedangkan persentase 
makrofag M2 tidak berbeda nyata diantara kelompok uji (p>0.05). Dapat disimpulkan, 
pemberian ekstrak etanol daun mahkota dewa dapat meningkatkan aktivitas makrofag 
pada tikus diabetes. Selain itu, pemberian ini juga dapat meningkatkan persentase 
makrofag M1 pada hari ke 14. 
Keywords: diabetes mellitus - peritoneal macrophage – phagocytosis - M1 macrophage 
- M2 macrophage 
INTRODUCTION
Diabetes mellitus (DM) is a metabolic 
disorder of endocrine characterized by 
hyperglycemia as the result of insulin 
deficiency, decrease in tissue insulin 
sensitivity or both.1 The prevalence of DM 
worldwide increased dramatically in the last 
20 years. The World Health Organization 
(WHO) estimated that the people with DM 
will increased to be 300 million in 2025 in 
the world.2 Indonesia is the fourth country 
with the highest people with DM in the world 
after India, China and America. In Indonesia, 
the people with DM reached 12.2 million in 
2013, it will be 21.3 million in 2030.3The 
pathogenesis of DM is associated with the 
inflammatory process which oxidative stress 
and chronic inflammation can induce insulin 
resistance. Diabetes mellitus is also the 
manifestation of inflammatory response such 
as migration and macrophage infiltration 
into the islets of Langerhans of pancreas, the 
increase in C-reactive protein, fibrinogen, 
pro-inflammatory cytokines (IL-6 and TNFα), 
and the decrease in IL-10. Oxidative stress 
in diabetes also increases the death of cells 
and apoptosis.4Macrophage is phagocytic 
cells in innate immunity system that plays an 
important role in inflammatory process and 
body immunity sytem. It consists of two sub-
populations, M1 and M2 macrophages. M1 
macrophages play their role in the inflammatory 
stage to produce pro-inflammatory cytokines 
such as TNF-α, IL-1β, IL-6, IL-12, IL-18 
and IL-23. They are transformed into M2 
macrophages in the resolution phase of 
inflammation. M2 macrophages produce anti-
inflammatory cytokines such as IL-10, TGFβ, 
IL-1Ra and IL-18BP.5 
Macrophages play their role in 
inflammation and infection in diabetic case. 
Activation of M1 macrophages induces 
inflammation and insulin resistance. M2 
macrophage activation can forestall pancreatic 
β cell auto antigen in type I diabetes mellitus 
and inhibit the development of type II 
diabetes.6,7 Dysfunction of innate immunity 
system and the decrease in phagocytic 
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activity of macrophages can increase the risk 
for infection in DM.8Phaleria macrocarpa 
(Scheff.) Boerl, locally well known as mahkota 
dewa, is an endogenous medicinal plant 
from Papua, Indonesia that widely used by 
Indonesian and Malaysian people. This plant 
is traditionally used to treat DM, allergy, liver 
diseases, vascular diseases, cancer, kidney 
failure, stroke, and hypertension. The parts of 
the plant used as medicine are stems, leaves, 
and fruit.9 The toxicity and mutagenicity of 
the P. macrocarpa (Scheff.) Boerl. fruit have 
been evaluated and showed that this fruit is 
safe for use as medicine.10,11 
Phaleria macrocarpa (Scheff.) Boerl. 
leaf contains the active compounds including 
flavonoids, polyphenols, saponins, tannin, and 
steroids which have anti-microbial effects.12,13 
Phalerin is a specifically active compound found 
in its leaf as an anti-inflammatory agent.14,15 
The extract of its leaf has been reported to 
have antihyperglycemic effects through the 
inhibition of α-glucosidase activity which 
is a carbohydrate-digesting enzymes.16 This 
plant also has antioxidant activity, tyrosinase 
inhibition, and analgesic effect.17,18 Ethanolic 
extract of P. macrocarpa (Scheff.) Boerl. leaf 
can increase splenic NK1.1 cells activity and 
macrophage phagocytic activity in mice.19 In 
this study we reported the effect of ethanolic 
extract of P. macrocarpa (Sheff.) Boerl leaf 
(EEPML) on macrophage phagocytic activity 
in diabetic rat model. Moreover, the M1 and 
M2 macrophage ratio was also determined.
MATERIALS AND METHODS
Extract preparation 
Phaleria macrocarpa (Scheff.) Boerl 
leaf was collected from Bantul District, 
Yogyakarta and identified in Department of 
Pharmaceutical Biology, Faculty of Pharmacy, 
Universitas Gadjah Mada, Yogyakarta, 
then dried and powdered. Powdered leaves 
were macerated with 70% ethanol at room 
temperature for 24 h and then filtered to 
separate filtrate from residue. The residue was 
remacerated three time and filtrates obtained 
were collected and dried using vacuum rotary 
evaporator to obtain dried extract. Extract 
preparation for testing was prepared in 5% 
polyethylene glycol (PEG) solution.
Diabetes animal model 
Forty five male Sprague Dawley rats aged 
eight weeks with the body weight (BW) of 200 
to 230 g obtained from the Integrated Research 
and Testing Laboratory, Universitas Gadjah 
Mada, Yogyakarta were used in this study. The 
rats were housed at room temperature under 
12 hours cycles of dark and light and fed a 
standard food as well as provided an access to 
aquadest ad libitum. After an acclimatization 
period of one week, the rats were then 
grouped into non diabetic or normal control 
group, diabetic control group and diabetic 
treatment group which given with 7; 14; 28 
mg/200 g BW of EEPML respectively, orally 
once a day for 3, 14 or 25 days according to 
their terminating groups. Diabetic rats were 
induced by single intraperitoneal injection 
of streptozotocin (STZ) at a dose of 65 mg/
kg BW and nicotimamide at 100 mg/kg BW. 
Fasting blood glucose level was examined on 
day 8 after STZ induction. Diabetic rats were 
diagnosed if blood glucose level was >170 
mg/dL. Protocol of the study was approved 
by the Ethical Commission for Preclinical 
Research of the Integrated Research and 
Testing Laboratory, Universitas Gadjah Mada, 
Yogyakarta.
Isolation and culture of peritoneal 
macrophages
The rats were sacrificed on day 3, 14 or 
25 according to their terminating groups. The 
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rats were anaesthetized by xylazin ketamine 
injection intramuscularly on their left thighs 
and cervical dislocation was performed on 
supine position. The abdomen skin was 
opened and the peritoneum sheath was cleaned 
up with 70% of ethanol. Approximately 10 
mL of cold RPMI medium were injected 
into the peritoneal cavity during 3 min while 
they were shaked slowly. Peritoneal fluid was 
excreted from peritoneal cavity by pressing 
the organ with two fingers. Aspirated fluid 
using injecting tube was conducted on non-
fat part and which was far from intestine. 
Aspirated centrifugation was at 1,200 rpm 
at the temperature of 4°C in 10 min. The 
established supernatant was removed and 3 
mL of complete RPMI medium on the pellet 
was added. The number of cells was counted 
with hemocytometer and their viability was 
determined by using trypan blue solution. 
The solution was re-suspended with complete 
RPMI medium so that cell suspension with the 
density of 2.5x106 cells/ mL was obtained. The 
calculated cell suspensions were inoculated 
in a 24-well plate, equipped with cover-slip 
with each well contained 200 mL suspension 
(5x105 cells). The cells were incubated in 
a 5% CO2 incubator at the temperature of 
37°C in 30 min, and 1 mL of complete RPMI 
medium was added in each well, followed by 
incubation within 2 h. The cells were washed 
with RPMI-1640 twice and 1 mL of complete 
RPMI medium was added in each well, 
followed by incubation within 24 h.
Macrophage phagocytic activity test
Latex beads were resuspended in PBS 
with 2.5x107/mL concentration. Peritoneal 
macrophages that had been cultured in the 
previous day were washed twice with RPMI-
1640. Suspension of latex beads (200 mL/
well) and the sample (200 mL/well) were 
added to each well and then were incubated in 
5% CO2 incubator at the temperature of 37°C 
in 60 min. Following after the incubation, 
cells were washed with PBS three times to 
remove the excess of latex beads, dried at a 
room temperature, and fixed with absolute 
methanol in 30 sec. The cells attached to cover 
slips were tinged with 20% of Giemsa in 20 
min then washed with distilled water. The 
percentage of 100 examined macrophage cells 
that phagocyte latex beads and the number of 
latex beads phagocyted by macrophages were 
counted by using a light microscope with 
400x magnification.
Flowcytometry analysis
Peritoneal macrophage cell suspension 
which contained approximately 5x105 cells 
was added with anti-CD40 antibody FITC 
(Ebioscience 11-0402-82) and anti-CD206 
antibody/MRC1 (BIOSs bs-4727R-Cy5.5) and 
incubated in 30 min at the temperature of 4°C. 
The cells were then washed twice, resuspended 
into pharmigen stain buffer, examined by using 
flowcytometer FACS Calibur, and analyzed by 
using Cell Quest software. The data obtained 
from the flowcytometry analysis constituted 
the percentage of M1 macrophages and M2 
macrophages.
Statistical analysis
Data of the percentage of active 
macrophages (AM), phagocytosis index (PI), 
and the percentage of M1 and M2 macrophages 
were presented as mean ± standard deviation 
(SD). Normality of data distribution was 
tested by using the Shapiro-Wilk. One way 
analysis of variance (Anova) and Tukey post 
hoct tests were used for normal distributed 
data. Non-parametric Kruskal Wallis and 
Mann Whitney post hoc tests were used for 
abnormal distributed data.
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FIGURE 1.  Macorphage phagocytic assay of normal control group (A) and diabetic 
treatment group (C) showed more active phagocyte latex beads (arrow) 
than diabetic control group (B). Giemsa staining, 400x magnification, 
scale 1:400µm.
RESULTS
The morphology of macrophages in 
normal control group and in the EEPML 
treatment groups were bigger with protruded 
cytoplasm and phagocyted many latex beads, 
while macrophages in diabetes control group 
were smaller and rounded and phagocyted 
fewer latex beads (FIGURE 1).
The mean of active macrophages 
(AM), phagocytic index (PI), M1 and M2 
macrophages of all groups on day 3, 14 and 
25 are presented in TABLE 1. 
TABLE 1. The mean of active macrophages (AM), phagocytic index (PI), M1 and M2 macrophages of all 
groups on day 3, 14 and 25 
Groups Parameter
Termination Treatment Active Macrophage (%) Phagocyitic Index
M1 Macrophage 
(%)
M2 Macrophage 
(%)
Day 3
N 
DM 
EEPML1 
EEPML2 
EEPML3
88.3±0.6 
77.3±1.2 
81.3±1.2 
78.7±2.1 
82.7±2.3
526.7±25.7 
323.3±30.9 
350.0±20.4 
369.3±33.8 
407.7±62.6
45.7±7.9 
28.8±7.8 
23.5±15.4 
38.9±4.6 
38.6±10.6
64.5±8.6 
57.4±17.6 
52.0±23.0 
70.2±13.1 
62.0±11.3
Day 14
N 
DM 
EEPML1 
EEPML2 
EEPML3
87.3±2.3 
65.0±2.7 
72.0±3.6 
87.3±5.0 
83.0±5.6
473.3±59.8 
275.3±59.3 
325.0±44.0 
383.0 ±56.7 
321.3±30.0
50.7±20.5 
48.1±24.3 
60.7±10.0 
69.4±7.1 
51.9±6.2
60.1±26.2 
59.1±28.0 
77.1±0.7 
76.1±2.3 
72.4±2.0
Day 25
N 
DM 
EEPML1 
EEPML2 
EEPML3
92.0±3.5 
76.3±6.0 
90.0±1.0 
90.7±3.1 
84.7±1.5
525.7±98.3 
259.7±30.1 
384.7±19.6 
341.0± 68.6 
335.0±87.7
51.2±2.2 
45.1±6.1 
46.5±4.9 
24.7±6.1 
46.4±16.0
74.8±3.4 
75.0±4.4 
74.7±9.1 
74.3±0.6 
74.1±1.6
p 0.000** 0.000* 0.002* 0.165**
Normality test with Saphiro-Wilk, performed by the mean value of ± SD. N: Normal control group; DM: diabetic 
control group; EEPML: diabetic treatment group at doses 7, 14 and 28 mg/200 g BW.*One way Anova, p<0.05 
significant, **Non parametric Kruskal Wallis, p<0.05 significant.
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(A) (B)
The mean of AM of the normal control 
group was significantly higher than that of the 
diabetic control group on all day of examination 
and than that of the diabetic treatment groups 
at all doses on day 3 (p<0.05). However, it 
was not significantly different compared to 
that of the diabetic treatment groups at doses 
of 14 and 28 mg/200g BW on day 7 and at all 
doses on day 14 (p>0.05). The means of AM 
of the diabetic treatment groups at all doses 
on day 3 and at dose of 7 mg/200g BW on day 
7 were not significantly different compared to 
those of the diabetic control group (p>0.05). 
However, at doses of 14 and 28 mg/200g BW 
on day 7 and at all doses on day 14, they were 
significantly higher than those of diabetic 
control group (p<0.05). The highest of the 
mean of AM in diabetic treatment groups was 
observed at dose of 14 mg/200g BW on day 
25 (FIGURE 2.A). 
The mean of PI of the normal control 
group was significantly higher than that 
of the diabetic control group on all day of 
examination and than that of the diabetic 
treatment groups at all doses on all day 
of examination (p<0.05). In addition, the 
means of PI of the diabetic treatment groups 
at all doses on all day of examination were 
significantly higher than that of the diabetic 
control group (p<0.05) (FIGURE 2.B).
FIGURE 2.  A) The mean of active macrophage (AM) and B) phagocytic index (PI) on day 3, 14 and 25; N: 
Normal control group; DM: diabetic control group; EEPML: diabetic treatment groups at doses 
of 7, 14 and 28 mg/200 g BW.
The mean of M1 macrophage percentage 
of the normal control group on day 3 was 
significantly higher than that of the diabetic 
control group on day 3 (p<0.05). However, 
it was not significantly different compared to 
that the diabetic control group on day 7 and 
14 (p>0.05). The means of M1 macrophage 
percentage of the diabetic treatment groups 
at doses of 14 and 28 mg/200g BW on day 
3 and at doses of 7 and 14 mg/200g BE on 
day 14 were significantly higher than that 
the diabetic control group on day 3 and 7, 
respectively (p<0.05). However, the means 
of M1 macrophage percentage of all groups 
on day 25 were not significantly different 
(p>0.05), except the mean of M1 macrophage 
percentage at dose of 14 mg/200g BW which 
was significantly lower than others groups 
(p<0.05) (FIGURE 3.A). Furthermore, the 
means of M2 macrophage percentage of all 
groups on all day of examination were not 
significantly different (p>0.05) (FIGURE 3.B).
J Med Sci, Volume 50, No. 2, 2018 April: 140-149
146
(A) (B)
FIGURE 3.  A) The mean value of M1 macrophage and B) M2 macrophage percentage on day 3, 14, and 25. 
*post hoc Tukey (p<0,05). N: Normal control group; DM: diabetic control group; EEPML: dia-
betic treatment groups at doses of 7, 14 and 28 mg/200 g BW.
DISCUSSION
Diabetes mellitus is associated with 
the innate immune system disturbance that 
caused patients with DM exhibit increased 
susceptibility to infection, impaired 
wound healing and other inflammatory or 
degenerative manifestations. Macrophages 
play important roles in controlling innate 
immune system.8,20 In this study, the decrease 
in macrophages activity was observed in 
diabetic rats as indicated by lower of the mean 
of AM and PI compared to normal rats on day 
3 and continued on day 14 and 25 (TABLE 1 
and FIGURE 2 and 3). 
The decrease in the macrophages 
activity may be caused by hyperglycemia 
condition in DM which leads to oxidative 
stress and glycation induced the cells death. 
Hyperglycemia also increases advanced 
glycation end product (AGE) formation that 
will be bound to the AGE receptor (RAGE) 
on the membrane of various cells, including 
macrophages. The bond of AGE-RAGE with 
macrophage cells can inhibit the macrophages 
phagocytic activity.21 In addition, inflammatory 
condition in DM can also induce the formation 
of inflammatory mediator of high mobility 
group box 1 (HGMB1) which can bind to 
phosphatidylserine on the membrane of 
apoptotic cells. This condition can inhibit the 
macrophage capacity to identify apoptotic cells 
and to perform efferocytosis on the apoptotic 
cells lead to inhibition of tissue repair.22 
The EEPML is potential to increase the 
peritoneal macrophage phagocytic activity and 
improve the function of immunity system in 
diabetic condition. The three doses of EEPML 
have similar effects to increase macrophages 
activity. However, the most effective dose 
of EEPML was 14 mg/200g BW. This dose 
EEPML could increase the macrophages 
activity similar to that normal control group 
on day 3, 14 and 25 (TABLE 1 and FIGURE 
2 and 3). The immunomodulatory effect of P. 
macrocarpa (Scheff.) Boerl. leaf extract has 
been reported in previous studies. Ghufron 
et al.19 reported that ethanolic extract of P. 
macrocarpa (Scheff.) Boerl. leaf can increase 
splenic NK1.1 cells activity and macrophage 
phagocytic activity in mice. Abood et al.20 
reported an immunomodulatory effect of 
P. macrocarpa (Scheff.) Boerl. and their 
isolated fraction by increasing macrophage 
cell proliferation and significant induce of 
cytokines INF-γ, IL-6 and IL-8 intracellular 
expression. 
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Macrophages play an important role 
in the inflammatory process in diabetic 
condition. This study showed the percentage 
of peritoneal M1 macrophages in diabetic 
control group significantly decreased on day 
3 compared to normal control group, while 
the percentage of peritoneal M2 macrophages 
was unchanged (FIGURE 3A and B). The 
decrease of the peritoneal M1 macrophage 
percentage was caused by the decrease in 
the macrophages phagocytic activity due 
to the immunity system dysfunction in 
diabetic condition. M1 macrophages are 
pro-inflammatory macrophages that play an 
active role in performing phagocytosis while 
M2 macrophages are anti-inflammatory 
macrophages that actively perform effecytosis 
to clean up apoptotic cells for tissue repair.6,21 
M2 macrophages are commonly accumulated 
in normal energy metabolism process involving 
mitochondria. Meanwhile, M1 macrophages 
are generally accumulated at edema, hypoxia, 
anaerobic glycolysis, inflammation, and 
insulin resistance condition.22The EEPML 
administration influenced the percentage of 
peritoneal M1 and M2 macrophages in diabetic 
condition. It could increase the mean of the 
percentage of peritoneal M1 macrophages 
especially on day 14 (FIGURE 3.A). The 
increase of the percentage of peritoneal M1 
macrophages can maximize inflammatory state 
of diabetes, together with the increase in the 
macrophage phagocytic activity induced by 
the EEPML administration. Moreover, it could 
also increase the mean of the percentage of 
peritoneal M2 macrophages on day 14, however 
it was not significantly different (FIGURE 3.B). 
The increase of the percentage of peritoneal 
M2 macrophages is caused by the increase 
of percentage of peritoneal M1 macrophages 
and its activity inducing the M1 macrophages 
polarization into M2 macrophages to relieve 
inflammatory conditions in diabetes. 
The result of this study is different 
from the previous study that reported the 
topically EEPML ointment administration 
on diabetic wound on rats can increase the 
M1 and M2 macrophages on day 3, however 
it decrease on day 14.23 The different may 
be caused by the macrophages used in 
these study. The inflammatory process in 
diabetic wound involves the tissue-resident 
macrophages distributed in the epidermis. In 
this study, we used peritoneal macrophages 
containing the combination of the tissue-
resident macrophages and monocytes derived 
macrophages from the systemic circulation.24,25 
The two types of macrophages might have the 
different time of activation. 
CONCLUSION
In conclusion, the ethanolic extract of P. 
macrocarpa (Sheff.) Boerl leaf administration 
can increase macrophage phagocytic activity 
in diabetic rats. In addition, it also can increase 
M1 macrophage percentage on day 14. This 
immunomodulatory effect of the plant extract 
could be used to improve the immunity system 
of diabetic conditions.
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